Keywords

#alectinib

Alectinib

ALK inhibitor for treatment of non-small-cell lung cancer

Alectinib (INN), sold under the brand name Alecensa, is an anticancer medication that is used to treat non-small-cell lung cancer (NSCLC). It blocks the activity of anaplastic lymphoma kinase (ALK). It is taken by mouth. It was developed by Chugai Pharmaceutical Co. Japan, which is part of the Hoffmann-La Roche group.

Mon 1st

Provided by Wikipedia

Learn More

This keyword could refer to multiple things. Here are some suggestions:

Alectinib ALK inhibitor Lung cancer Roche Crizotinib List of drugs by year of discovery Genentech List of drugs granted breakthrough therapy designation Lorlatinib Elranatamab
0 searches
This keyword has never been searched before
This keyword has never been searched for with any other keyword.